Discontinued — last reported Q1 '18
First Solar Allowance for Doubtful Accounts Receivable (Current) increased by 13.7% to $15.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 91.1%, from $7.89M to $15.08M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 34.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.48M | $1.43M | $664.00K | $479.00K | $607.00K | $570.00K | $1.04M | $1.01M | $1.29M | $4.21M | $1.61M | $1.90M | $1.68M | $608.00K | $1.30M | $7.89M | $9.31M | $11.40M | $13.27M | $15.08M |
| QoQ Change | — | -42.3% | -53.6% | -27.9% | +26.7% | -6.1% | +82.8% | -3.3% | +27.5% | +227.3% | -61.6% | +17.9% | -11.9% | -63.7% | +114.5% | +505.4% | +17.9% | +22.5% | +16.4% | +13.7% |
| YoY Change | — | — | — | — | -75.5% | -60.1% | +56.9% | +110.4% | +111.7% | +637.9% | +54.9% | +88.8% | +30.4% | -85.5% | -19.2% | +314.8% | +455.3% | >999% | +917.4% | +91.1% |